Crestline Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$453K Buy
2024
Q3
$406K Buy
2022
Q1
Sell
2021
Q4
$219K Sell
2021
Q3
$5.23M Buy